Stock

Evolent Health, Inc EVH

$4.66-16.28%

All stocks Create account to unlock

Overview

EVH market data

Price History

EVH price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for EVH. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

8 captured

Evolent Health shares are trading lower after Citigroup downgraded the stock from Buy to Neutral. · Jul 23, 2026, 5:25 PM

Citigroup Downgrades Evolent Health to Neutral, Raises Price Target to $6.75 · Jul 23, 2026, 11:25 AM

Canaccord Genuity Maintains Buy on Evolent Health, Raises Price Target to $7 · Jul 21, 2026, 11:23 AM

Truist Securities Downgrades Evolent Health to Hold, Maintains Price Target to $7 · Jun 30, 2026, 1:55 PM

Truist Securities Maintains Buy on Evolent Health, Raises Price Target to $7 · Jun 12, 2026, 2:15 PM

Rumble, Agilon Health And Oscar Health Among Stocks Moving Higher On Thursday · Jun 4, 2026, 2:55 PM

Citigroup Maintains Buy on Evolent Health, Raises Price Target to $5.5 · May 15, 2026, 6:28 PM

8-K filing — Evolent Health, Inc. (EVH) · May 7, 2026, 11:05 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock